当前位置：
X-MOL 学术
›
J. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
Journal of Clinical Oncology ( IF 42.1 ) Pub Date : 2024 , DOI: 10.1200/jco.24.00003 Alice Y. Ho, Stephen Shiao, Samantha A. Kobald, Jonathan Chen, Dan G. Duda, Amy Ly, Veerle Bossuyt, Hae Lin Cho, Brittany Arnold, Simon Knott, Gaorav P. Gupta, Philomena McAndrew, Scott Karlan, Mourad Tighiouart, Alona Muzikansky, Reva Basho, Heather McArthur
Journal of Clinical Oncology ( IF 42.1 ) Pub Date : 2024 , DOI: 10.1200/jco.24.00003 Alice Y. Ho, Stephen Shiao, Samantha A. Kobald, Jonathan Chen, Dan G. Duda, Amy Ly, Veerle Bossuyt, Hae Lin Cho, Brittany Arnold, Simon Knott, Gaorav P. Gupta, Philomena McAndrew, Scott Karlan, Mourad Tighiouart, Alona Muzikansky, Reva Basho, Heather McArthur
Journal of Clinical Oncology, Ahead of Print.
中文翻译：
PEARL：人表皮生长因子受体 2 阴性乳腺癌新辅助化疗前 Pembrolizumab 加放射治疗的 Ib/II 期生物标志物研究
临床肿瘤学杂志，提前印刷。
更新日期：2024-09-20
中文翻译：
PEARL：人表皮生长因子受体 2 阴性乳腺癌新辅助化疗前 Pembrolizumab 加放射治疗的 Ib/II 期生物标志物研究
临床肿瘤学杂志，提前印刷。
京公网安备 11010802027423号